D. Western Therapeutics Institute Inc. also released the following forecasts: | |
GROUP | Year Ending |
Dec 2025 | |
Revenue | Y400.00 mln |
Operating Profit | (Y670.00 mln) |
Pretax Profit | (Y680.00 mln) |
Net Profit | (Y680.00 mln) |
Per share | |
Earnings | (Y15.88) |
Figures in parentheses are losses. | |
Results are based on Japanese accounting standards. |
(END) Dow Jones Newswires
D. Western Therapeutics Institute Inc. (4576.TO) | ||
Japan | ||
1st Quarter Ended March 31 | ||
GROUP | 2025 | 2024 |
Revenue | Y96.00 mln | Y104.00 mln |
Operating Profit | (Y142.00 mln) | (Y318.00 mln) |
Pretax Profit | (Y149.00 mln) | (Y320.00 mln) |
Net Profit | (Y150.00 mln) | (Y320.00 mln) |
Per share | ||
Earnings | (Y3.41) | (Y9.99) |
Figures in parentheses are losses. | ||
Results are based on Japanese accounting standards. |
This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(END) Dow Jones Newswires
May 15, 2025 02:42 ET (06:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。